NCT00758407View on ClinicalTrials.gov

Methylphenidate Treatment of Cancer-Related Fatigue

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

January 31, 2010

Conditions
Cancer-related Fatigue
Interventions
DRUG

Methylphenidate hydrochloride

sustained release, dosage according to an individual titration schedule

DRUG

Placebo

dosage according to an individual titration schedule

Trial Locations (6)

Unknown

Sonnenbergklinik, Bad Sooden-Allendorf

Dr. J.-U. Rüffer, Cologne

Praxis Dr. Lathan, Dortmund

Praxis Dr. Verpoort - Dr. Zeller, Hamburg

Medizinische Fakultät der Universität Leipzig, Leipzig

Medizinisches Versorgungszentrum - MOP, München

All Listed Sponsors
lead

Medice Arzneimittel Pütter GmbH & Co KG

INDUSTRY

NCT00758407 - Methylphenidate Treatment of Cancer-Related Fatigue | Biotech Hunter | Biotech Hunter